glp-1 drugs for parkinson's disease How a 'blockbuster' treatment diabetes and obesity might slow or stop – Van Andel Institute Glucagon-like peptide-1 medicines in neurological
Description
The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line
Brown JC, Mutt V, Pederson RA
Economic losses: Lost income, diminished earning capacity, and future treatment costs projected by life-care planners
Of note, the 2022 study [19] was initially identified in our literature search as a 2021 conference abstract and was subsequently published in a journal during preparation of a revision of our manuscript
10.1093/advances/nmy087 [DOI] [PMC free article] [PubMed] [Google Scholar] 46
